Edition:
India

Dr. Lal PathLabs Ltd (DLPA.NS)

DLPA.NS on National Stock Exchange of India

1,535.95INR
10 Dec 2019
Change (% chg)

-- (--)
Prev Close
Rs1,535.95
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
116,058
52-wk High
Rs1,698.50
52-wk Low
Rs890.95

Latest Key Developments (Source: Significant Developments)

India's Dr. Lal Pathlabs Dec-Qtr Net Profit Rises
Friday, 8 Feb 2019 

Feb 8 (Reuters) - Dr. Lal PathLabs Ltd ::DEC QUARTER CONSOL NET PROFIT 458 MILLION RUPEES VERSUS 360 MILLION RUPEES YEAR AGO.DEC QUARTER CONSOL REVENUE FROM OPERATIONS 2.93 BILLION RUPEES VERSUS 2.63 BILLION RUPEES YEAR AGO.  Full Article

Dr. Lal Pathlabs Says NCLT Sanctioned Scheme Of Amalgamation With Delta Ria And Pathology
Friday, 14 Dec 2018 

Dec 14 (Reuters) - Dr. Lal PathLabs Ltd ::NCLT SANCTIONED SCHEME OF AMALGAMATION BETWEEN CO AND DELTA RIA AND PATHOLOGY PVT LTD.  Full Article

Dr. Lal Pathlabs March-qtr Consol Profit Rises
Monday, 14 May 2018 

May 14 (Reuters) - Dr. Lal PathLabs Ltd ::RECOMMENDED DIVIDEND OF 3 RUPEES PER SHARE.MARCH QUARTER CONSOL PROFIT 401 MILLION RUPEES VERSUS PROFIT 314 MILLION RUPEES YEAR AGO.MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 2.67 BILLION RUPEES VERSUS 2.20 BILLION RUPEES YEAR AGO.  Full Article

Dr.Lal Pathlabs Says NCLT Ordered Meetings of Shareholder, Unsecured Creditors For Amalgamation Scheme With Delta Ria And Pathology​​
Friday, 29 Dec 2017 

Dec 29 (Reuters) - Dr. Lal Pathlabs Ltd ::NCLT ORDERED MEETINGS OF SHAREHOLDERS, UNSECURED CREDITORS TO APPROVE SCHEME OF AMALGAMATION BETWEEN CO & DELTA RIA AND PATHOLOGY​.  Full Article